美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
70436-060-02	70436-060	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride SR	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20201102	N/A	ANDA	ANDA211347	Slate Run Pharmaceuticals, LLC	BUPROPION HYDROCHLORIDE	200 mg/1	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-060-02)
70436-060-05	70436-060	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride SR	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20201102	N/A	ANDA	ANDA211347	Slate Run Pharmaceuticals, LLC	BUPROPION HYDROCHLORIDE	200 mg/1	60 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-060-05)
70436-058-05	70436-058	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride SR	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20201102	N/A	ANDA	ANDA211347	Slate Run Pharmaceuticals, LLC	BUPROPION HYDROCHLORIDE	100 mg/1	60 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-058-05)
70436-058-01	70436-058	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride SR	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20201102	N/A	ANDA	ANDA211347	Slate Run Pharmaceuticals, LLC	BUPROPION HYDROCHLORIDE	100 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-058-01)
70436-059-01	70436-059	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride SR	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20201102	N/A	ANDA	ANDA211347	Slate Run Pharmaceuticals, LLC	BUPROPION HYDROCHLORIDE	150 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-059-01)